252 related articles for article (PubMed ID: 21271310)
1. The role of matrix metalloproteinases in atherothrombosis.
Ketelhuth DF; Bäck M
Curr Atheroscler Rep; 2011 Apr; 13(2):162-9. PubMed ID: 21271310
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in atherothrombosis.
Bäck M; Ketelhuth DF; Agewall S
Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
Olejarz W; Łacheta D; Kubiak-Tomaszewska G
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and atherosclerosis.
Watanabe N; Ikeda U
Curr Atheroscler Rep; 2004 Mar; 6(2):112-20. PubMed ID: 15023295
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.
Ruddy JM; Ikonomidis JS; Jones JA
J Vasc Res; 2016; 53(1-2):1-16. PubMed ID: 27327039
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
Brown BA; Williams H; George SJ
Prog Mol Biol Transl Sci; 2017; 147():197-237. PubMed ID: 28413029
[TBL] [Abstract][Full Text] [Related]
9. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
10. Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Goncalves I; Bengtsson E; Colhoun HM; Shore AC; Palombo C; Natali A; Edsfeldt A; Dunér P; Fredrikson GN; Björkbacka H; Östling G; Aizawa K; Casanova F; Persson M; Gooding K; Strain D; Khan F; Looker HC; Adams F; Belch J; Pinnoli S; Venturi E; Kozakova M; Gan LM; Schnecke V; Nilsson J;
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1723-31. PubMed ID: 25953645
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Kampoli AM; Tousoulis D; Papageorgiou N; Antoniades C; Androulakis E; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1192-205. PubMed ID: 22519449
[TBL] [Abstract][Full Text] [Related]
12. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinases and atherosclerosis].
Fic P; Zakrocka I; Kurzepa J; Stepulak A
Postepy Hig Med Dosw (Online); 2011 Jan; 65():16-27. PubMed ID: 21357991
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and peripheral arterial disease.
Busti C; Falcinelli E; Momi S; Gresele P
Intern Emerg Med; 2010 Feb; 5(1):13-25. PubMed ID: 19626421
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
17. Extreme Levels of Air Pollution Associated With Changes in Biomarkers of Atherosclerotic Plaque Vulnerability and Thrombogenicity in Healthy Adults.
Xu H; Wang T; Liu S; Brook RD; Feng B; Zhao Q; Song X; Yi T; Chen J; Zhang Y; Wang Y; Zheng L; Rajagopalan S; Li J; Huang W
Circ Res; 2019 Mar; 124(5):e30-e43. PubMed ID: 30661461
[TBL] [Abstract][Full Text] [Related]
18. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
Schäfers M; Schober O; Hermann S
J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
[TBL] [Abstract][Full Text] [Related]
19. Proteinases and plaque rupture: unblocking the road to translation.
Newby AC
Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]